FIELD: medicine, pharmaceutics.
SUBSTANCE: the present insulin solution for peroral intake should be applied for treating patients with diabetes mellitus. The suggested insulin solution consists of water and insulin, additionally, it contains sodium chloride at the following ratio of components, weight%: insulin 0.005-0.02, sodium chloride 0.5-1.0, water - up to 100.0. The innovation provides decreased glucose level in blood of animals in case of peroral intake of the solution up to 40% at insulin dosages being about 10 U/kg animal body weight.
EFFECT: higher efficiency.
12 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2519099C1 |
| POLYPEPTIDE COMPOSITION | 1999 |
|
RU2171687C2 |
| SOLID INSULIN-CONTAINING DRUG | 1997 |
|
RU2117488C1 |
| METHOD OF PREPARING INSULIN-CONTAINING POLYMERIC HYDROGEL | 1994 |
|
RU2066551C1 |
| METHOD OF INSULIN DERIVATIVES PREPARING | 1994 |
|
RU2076733C1 |
| INSULIN-CONTAINING DRUG FOR ORAL USING AND METHOD OF ITS PREPARING | 1999 |
|
RU2155602C1 |
| METHOD FOR PRODUCING INSULIN-CONTAINING COMPOSITION | 2020 |
|
RU2752509C1 |
| METHODS OF REGULATION OF GASTROENTERIC TRACT MOTOR SYSTEM | 1994 |
|
RU2177331C2 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| METHOD FOR TREATING DIABETES TYPE II WITH AMYLENE ANTAGONISTS | 1996 |
|
RU2166958C2 |
